CRP and Hypoalbuminemia: Both studies included patients with mixed solid tumors in the pre-treatment phase (30, 35) and found GPS 2 (elevated CRP and hypoalbuminemia) to be significantly associated with deficit accumulation frailty (Balducci criteria and Edmonton Frailty Scale).